Evidence map›Paper›PMID 18823025›Full record

ArticleCancer2008

Genetic variations in cell-cycle pathway and the risk of oral premalignant lesions.

Yuanqing Ye, Scott M Lippman, J Jack Lee, Meng Chen, Marsha L Frazier, Margaret R Spitz, Xifeng Wu

Open access · greenAbstract readComparative Study
In one paragraph

Article in Cancer, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Diverse roles of bitter melon (Journal of cancer metastasis and treatment · 2021
    Article
  4. Article
  5. Review
  6. Combination of genetic variants in cyclin D1 and retinoblastoma genes predict clinical outcome in oral cancer patients.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yuanqing YeDepartment of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
Scott M Lippman
J Jack Lee
Meng Chen
Marsha L Frazier
Margaret R Spitz
Xifeng Wu
The University of Texas MD Anderson Cancer Center · USUniversity of Houston · US

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DIANE M SIMEONE · 1985 to 2026
$124.9M
Targeting the p53 pathway for reversal of oral premalignancyP50CA097007 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MYERS, JEFFREY NICHOLAS · 2002 to 2012
$26.1M
TARGETING COX-2 AND EGFR SIGNALING IN ORAL CARCINOGENESISP01CA106451 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LIPPMAN, SCOTT M · 2004 to 2009
$8.3M
CLINICAL AND EPIDEMIOLOGIC CENTER FOR BIOMARKERS OF UPPEU01CA086390 · NCI · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI SPITZ, MARGARET R · 2000 to 2004
$4.3M
NCI NIH HHS CA097007NCI NIH HHS CA106451NCI NIH HHS CA86390NCI NIH HHS P01 CA106451NCI NIH HHS P30 CA023100NCI NIH HHS P50 CA097007
6 · The paper itself

Abstract

backgroundCell-cycle checkpoint controls regulate cell-cycle progression and proliferation. Alterations in cell-cycle control mechanisms are linked to tumorigenesis.

methodsThis case-control study included 147 cases and 147 controls. The authors used a pathway-based approach to assess the association between 10 potential functional single-nucleotide polymorphisms from 7 cell-cycle control genes and the risk of oral premalignant lesions (OPLs). They also used classification and regression tree analysis to examine high-order gene-gene and gene-smoking interactions.

resultsCompared with the homozygous wild-type GG genotype of CCND1 P241P, individuals with the AG genotype exhibited an increased risk of OPL (odds ratio, 1.58; 95% confidence interval, 0.89-2.83), and carriers of the AA genotype had a significantly increased risk of OPL (odds ratio, 2.75; 95% confidence interval, 1.33-5.71), with risk increasing significantly with the increasing number of variant alleles (P= .006). The risk of OPL increased significantly as the number of unfavorable genotypes in the pathway increased (P= .002). The final decision tree in the classification and regression tree analysis contained 5 terminal nodes. Compared with the never smokers (the lowest risk group), the odds ratios for terminal nodes 2 through 5 ranged from 1.21 to 5.40.

conclusionsThe results illustrated the advantage of using a pathway-based approach for analyzing gene-gene and gene-smoking interactions. Specifically, the authors showed that genetic polymorphisms in cell-cycle control pathway genes may contribute to the risk of OPL.

Indexed as

Case-Control StudiesCell Cycle ProteinsCyclin D1FemaleGenetic Predisposition to DiseaseGenotypeHumansMaleMiddle AgedMouth NeoplasmsPolymorphism, GeneticPrecancerous ConditionsRisk FactorsSmokingCCND1 protein, humanCell Cycle ProteinsCyclin D1

Identifiers

PMID18823025
PMCPMC2577230
OpenAlexW2066511274

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.